Description
Specifications
- Form: Sterile liquid solution / lyophilized powder
- Standard vial size: 60mg (peptide content), 10mL vial
- Composition: Low-molecular-weight peptide fragments derived from porcine brain tissue
- Storage: Refrigerate at 2–8°C, protect from light
Overview
Cerebrolysin is a complex mixture of low-molecular-weight neuropeptides and free amino acids derived via standardized enzymatic breakdown of brain proteins, extensively studied in neuroprotection and neurorehabilitation research for decades.
Mechanism & Research Findings
Cerebrolysin’s peptide fragments are studied for multimodal activity resembling endogenous neurotrophic factors, including effects analogous to BDNF, NGF, and GDNF signaling, with research reporting reduced neuronal apoptosis, modulation of neuroinflammation, and enhanced synaptic plasticity markers in animal injury models. Because it is a mixture rather than a single defined peptide, it is often used in comparative research as a positive-control neurotrophic intervention against single-target neuropeptide candidates.
Research Applications
- Multimodal neurotrophic factor-mimetic research
- Neuronal apoptosis and neuroinflammation studies
- Comparative positive-control research in CNS injury models
For laboratory research use only. Not for human consumption, diagnostic, or therapeutic use.


Reviews
There are no reviews yet.